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ABSTRACT Rhinovirus (RV) is an important trigger
of chronic obstructive pulmonary disease (COPD) ex-
acerbations. In addition, respiratory viruses are more
likely to be isolated in patients with a history of
frequent exacerbations, suggesting that these patients
are more susceptible to viral infection. To examine
potential mechanisms for cooperative effects between
bacterial and viral infection in COPD, we studied the
responses of cultured human airway epithelial cells to
nontypeable Hemophilus influenzae and RV. In both
16HBE14o- and primary mucociliary-differentiated
cells, preincubation with H. influenzae enhanced RV
serotype 39-induced protein expression of interleukin
(IL)-8, epithelial-derived neutrophil attractant-78, and
growth-related oncogene-. H. influenzae infection also
increased the binding of RV39 to cultured cells, as well
as expression of intercellular adhesion molecule
(ICAM)-1 and Toll-like receptor (TLR)-3, receptors for
RV and dsRNA, respectively. Neutralizing antibody
against tumor necrosis factor- inhibited IL-8 expres-
sion induced by H. influenzae and RV39. Finally, siRNA
against TLR3 attenuated RV-induced IL-8 expression.
We conclude that H. influenzae infection increases air-
way epithelial cell ICAM-1 and TLR3 expression, lead-
ing to enhanced binding of RV and a potentiation of
RV-induced chemokine release. These data provide a
cellular mechanism by which H. influenzae infection may
increase the susceptibility of COPD patients to RV-
induced exacerbations.—Sajjan, U. S., Jia, Y., New-
comb, D. C., Bentley, J. K., Lukacs, N. W., LiPuma, J. J.,
Hershenson, M. B. H. influenzae potentiates airway
epithelial cell responses to rhinovirus by increasing
ICAM-1 and TLR3 expression FASEB J. 20,
E1419–E1429 (2006)
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Chronic obstructive pulmonary disease (COPD),
is a chronic progressive disease with intermittent acute
exacerbations associated with viral and/or bacterial
infections. Nontypeable H. influenzae has been isolated
from airways of clinically stable COPD patients (1–3),
suggesting that it can cause chronic infection. Exacer-
bations of COPD have been associated with intracellu-
lar nontypeable Hemophilus influenzae (4) and acquisi-
tion of new strains of H. influenzae, Moraxella catarrhalis,
Streptococcus pneumoniae (5), and, in patients with se-
verely reduced lung function, Enterobacter and Pseudo-
monas species (6). Thus, it has been estimated that
bacterial infection is responsible for about half of
COPD exacerbations (7).
Rhinovirus (RV), a single-stranded RNA virus that is
responsible for most of the common colds, is also
important trigger of acute exacerbations in COPD
patients. Between 27–56% of COPD exacerbations are
associated with respiratory viral infections, and RV is
the most common virus isolated (8–10). Although RV
has not been cultured from the lower airways (11), it is
found in bronchial epithelial cells after infection of
human volunteers (12, 13). In COPD exacerbations, RV
is recovered from sputum more often than from nasal
aspirates, consistent with the idea that RV can infect
lower airways and contribute to inflammatory changes
(14). Respiratory viruses are more likely to be isolated
in patients with a history of frequent COPD exacerba-
tions (9), suggesting that patients with frequent exac-
erbations are more susceptible to viral infection (15).
Neutrophil number and the chemokines interleukin
(IL)-8 and epithelial-derived neutrophil attractant
(ENA)-78 (also known as CXCL5) are increased in the
sputum and airways of patients with COPD exacerba-
tions (16–20). IL-8 and ENA-78 are C-X-C chemokines
that contain the neutrophil-activating glutamic acid-
leucine-arginine (ELR) amino acid motif. Thus, RV
may stimulate COPD exacerbations by inducing bron-
chial epithelial cell production of IL-8 and ENA-78,
leading to an exaggerated neutrophilic inflammatory
response.
Expression of intercellular adhesion molecule
(ICAM)-1, the receptor for major subtype RV, is in-
1 Correspondence: University of Michigan, 1150 W. Medi-
cal Center Dr., Rm. 3570, MSRBII, Box 0688, Ann Arbor, MI
48109-0688, USA. E-mail: mhershen@umich.edu
doi: 10.1096/fj.06-5806fje
E14190892-6638/06/0020-1419 © FASEB
creased in the airway epithelium of patients with
chronic bronchitis and airway obstruction (21), and H.
influenzae stimulates ICAM-1 expression on respiratory
epithelial cells (22), suggesting a mechanism for addi-
tive or synergistic effects between bacterial and viral
infection. Nevertheless, little information exists regard-
ing potential interactions between viruses and bacteria
in the pathogenesis of COPD exacerbations. For exam-
ple, the effects of prior bacterial infection on binding
of RV to airway epithelial cells, or on RV-induced
responses, have not been studied.
In the present study, we investigated the cooperative
effects of H. influenzae and RV on ELR() C-X-C
chemokine production from airway epithelial cells. We
hypothesized that H. influenzae infection increases ex-
pression of airway epithelial cell ICAM-1 and Toll-like
receptor (TLR)-3, leading to increased RV binding and
exaggerated RV-induced chemokine responses.
MATERIALS AND METHODS
Cell culture
Human primary airway epithelial cells obtained from the
tracheal trimmings of donor lungs at the time of double lung
transplantation were cultured in collagen-coated plates using
bronchial epithelial cell culture media (BEGM; Cambrex
Bioscience, Walkersville, MD), as described previously (23).
Cells were stored in liquid nitrogen until required. To obtain
airway epithelial cells differentiated into mucociliary phenotype,
epithelial cells frozen at passage one were seeded on collagen-
coated transwells and grown under submerged conditions in
BEGM until the cells were confluent. The cells were shifted to
air/liquid interface and maintained in 1:1 mixture of BEGM
and Dulbecco’s modified Eagle’s medium (DMEM) for 2 wk.
16HBE14o- human bronchial epithelial cells originating
from bronchial epithelial tissue transfected with pSVori-,
containing the origin-defective SV40 genome (24), were
provided by Dr. Steven White (University of Chicago). Cells
were grown in minimum essential medium supplemented
with 10% FBS and 2 mM of l-glutamine. Human epithelial
kidney (HEK) 293 cells with stable TLR3 expression and
vector control cells were and propagated in DMEM contain-
ing 2 mM l-glutamine, 10% FBS, and 530 g/ml G418.
Bacteria and growth conditions
H. influenzae strain 12, a well-characterized nontypeable clin-
ical strain originally isolated from a middle ear infection (25),
was kindly provided by Dr. Graham Krasan (University of
Michigan). H. influenzae was maintained as a glycerol stock at
80°C, subcultured on blood agar plates, and incubated
overnight at 37°C/5% CO2. Bacteria were scrapped off of the
plate and suspended in cell culture medium devoid of serum
and antibiotics to the required concentration. In selected
experiments, bacteria were incubated at 80°C for 30 min with
occasional mixing. This treatment killed 100% of the bacte-
ria, as determined by dilution plating.
Rhinovirus
RV serotype 39 (RV39) was obtained from American Type
Culture Collection (Manassas, VA). Viral stocks were gener-
ated by infecting HeLa cells with RV until 80% of the cells
were cytopathic. Hela cell lysates or supernatants were har-
vested, and cellular debris was pelleted by centrifugation
(10,000 g for 30 min at 4°C). RV was concentrated and
partially purified by centrifugation with a 100,000 molecular
weight cutoff Centricon filter (2,000 rpm at 4°C for 8 h;
Millipore, Billerica, MA; ref 26). TCID50 values of viral stocks
were determined by the Spearman-Karber method (27).
Similarly treated HeLa cell lysates from mock-infected cells
served as controls (sham media controls). To generate 35S-
labeled RV39, HeLa cells were shifted to methionine and
cysteine-free DMEM containing 35S-labeled cysteine and me-
thionine, infected with RV39 as before, and incubated for
48 h. Culture supernatant was collected, clarified by centrif-
ugation, concentrated by ultrafiltration, and finally precipi-
tated with 6% polyethylene glycol overnight. Precipitate-
containing virus was dissolved in 0.5 ml sterile PBS.
Infection of cell cultures
All cell cultures were shifted to serum- and antibiotic-free
medium at least 18 h before infection with H. influenzae. For
cultures grown at air/liquid interface, the apical surface of
the cultures was infected with 50 l PBS or PBS containing
1  105 or 1  106 colony-forming units of H. influenzae and
incubated for 8 h. The apical surface was then washed, the
medium in the basolateral chamber was replaced, and the
apical surface was infected with 50 l RV39, multiplicity of
infection (MOI) of 0.5, 1, or 5, or sham-infected media
controls. After a 2 h incubation period, medium from apical
surface was removed, and the cells were further incubated for
24 or 48 h at 33°C. Basolateral medium and apical washings
were collected separately, centrifuged, and supernatants were
used for chemokine analysis. An optimal response to RV39
was observed at MOI of 1 and 24 h incubation period; these
conditions were used for subsequent experiments.
For submerged cultures of 16HBE14o- cells, HEK293 cells
with stable TLR3 expression, or vector control cells, bacteria
were added to the medium at MOI of 1 or 10 and incubated
for 8 h. Medium along with unbound bacteria were removed
and replaced with either RV39 (MOI of 1) or sham-infected
medium and incubated for 1 h at 33°C. The medium was then
replaced, and the cells were incubated for an additional 24 h.
Medium was collected and centrifuged, and the supernatant
was used for chemokine analysis. In selected experiments,
cells were preincubated with neutralizing Ab against tumor
necrosis factor (TNF)- or TNF receptor I (TNFRI; R&D
Systems, Minneapolis, MN). In some experiments, RV in-
fection was confirmed by reverse transcriptase-polymerase
chain reaction (RT-PCR) using primer pairs based on the 5
untranslated region which amplify both major and minor
serotypes of RV. Primer pairs used were 5TGGCAGATGAG-
GCTAGAAATACCCCAGTG3 (forward primer) and 5CAT-
CCCGCAATTGCTCGTTAC3 (reverse primer).
Binding of RV39 to 16HBE14o-cells
16HBE14o- cells were grown in 12 wells until 80% confluency.
Cells were shifted to serum- and antibiotic-free medium for at
least 18 h and infected with H. influenzae at a MOI of 1 for 8 h.
Unbound bacteria were removed and replaced with fresh
serum-free medium for another 16 h. Medium was replaced
with PBS-BSA (PBS containing 1% BSA) or PBS-BSA contain-
ing 10 mM EDTA for 1 h at 4°C and then incubated with
prechilled PBS-BSA containing 35S-labeled RV or equal vol-
umes of 35S-labeled sham control in the presence or absence
of 10 mM EDTA for 1 h at 4°C. Cells were washed with
PBS-BSA or PBS-BSA containing 10 mM EDTA to remove
unbound RV. Cells were then lysed with 0.1% SDS, and
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radioactive counts of the lysates were determined. To obtain
an estimate of specific binding of RV to epithelial cells, we
subtracted the counts per minute (CPM) bound in the
presence of EDTA from CPM bound in the absence of EDTA,
as described previously (28). We then subtracted the CPM
recovered from cells incubated with labeled sham control.
Quantification of chemokines and cytokines
The C-X-C chemokines IL-8, ENA-78, growth related onco-
gene (GRO)-, and the cytokine TNF- were measured using
Duoset ELISA development kits purchased from R&D Sys-
tems.
Transfection of cells and measurement of IL-8 promoter
activity
16HBE14o- cells grown in 6-well plates were transiently trans-
fected with the 162/44 fragment of the human IL-8
promoter subcloned into a luciferase reporter (hIL-8/Luc,
provided by Dr. Allan Brazier, University of Texas-Galveston;
ref 29) and Renilla luciferase using Lipofectamine 2000
(Invitrogen, CA). The following day the cells were shifted to
serum-free media and infected with H. influenzae at a MOI of
1 or 10 for 8 h, followed by RV (5105 TCID50) for 1 h.
Inoculum was replaced with fresh serum-free medium and
incubated at 33°C for 18 h, and the cells were harvested for
analysis. Luciferase activity was measured using a luminom-
eter. Changes in promoter activity were normalized for trans-
fection efficiency by dividing luciferase light units by renilla
luciferase light units. Results were then reported as fold
increase over the empty vector/untreated control.
To determine the requirement of TLR3 for RV39-induced
IL-8 expression, cells were transfected with TLR3 siRNA
(from Santa Cruz Biotechnologies, Santa Cruz, CA, and
Dharmacon, LaFayette, CO) along with hIL-8/Luc and Re-
nilla luciferase. Cells transfected with nontargeting siRNA
(Dharmacon) served as controls. To establish and optimize
siRNA transfections, we used varying concentrations of spe-
cific and nontargeting siRNA, ranging from 5 to 60 pmol, and
determined the expression of TLR3 by immunoblotting. We
found that, at the 10 pmol concentration, TLR3-specific but
not nontargeting siRNA inhibited TLR3 protein expression.
Hence, we used this concentration in subsequent experi-
ments.
Western blot analysis
Transfected 16HBE14o- cells were washed briefly in PBS,
lysed in radio-immunoprecipitation assay (RIPA) buffer con-
taining 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
Nonidet P-40, and 0.25% sodium deoxycholate containing
complete protease inhibitors (Roche, Indianapolis, IN); ho-
mogenized by passing through a 28 gauge needle; and
centrifuged. Supernatants were subjected to SDS-PAGE, pro-
teins were transferred to nitrocellulose, and the membrane
was probed with Ab to TLR3 (Santa Cruz Biotechnology).
Bound Ab was detected by secondary Ab conjugated to
horseradish peroxidase, and the signal was detected by chemi-
luminescence.
Flow cytometry
After relevant treatment, 16HBE14o- cells were harvested
using cell dissociating buffer (Invitrogen, Carlsbad, CA) and
washed with PBS-BSA (PBS containing 0.5% BSA). Cells were
washed with PBS-BSA, incubated with polyclonal antibody
(pAb) to TLR3 (5 g/ml, Santa Cruz Biotechnology), mono-
clonal antibody (mAb) to ICAM-1 (1 g/ml, Serotec, Raleigh,
NC), or matched isotype IgG control for 1 h on ice. Cells were
washed and incubated for 30 min on ice with the correspond-
ing second Ab conjugated to Alexa Fluor 488 (5 g/ml,
Molecular Probes, Portland, OR). For intracellular staining,
cells were permeabilized by incubating in PBS-BSA contain-
ing 2% paraformaldehyde and 0.1% saponin (30) for 30 min
on ice; cells were then incubated with primary and secondary
antibodies as described above. Cells were washed, suspended
in PBS-BSA, and analyzed with a Becton Dickinson FACSCali-
bur using CellQuest software.
Immunochemistry
Primary airway epithelial cells grown at air/liquid interface
were fixed in methanol at20°C after relevant treatment and
blocked with normal donkey serum. Cells were incubated
with appropriate dilutions of anti-TLR3 or ICAM-1 (R&D
systems), and the bound Ab was detected with anti-goat (for
TLR3) or anti-mouse (for ICAM-1) IgG conjugated with Alexa
Fluor-488. Cells were visualized by confocal microscopy using
a Zeiss LSM 510 confocal microscope mounted on a Zeiss
Axiovert 100M inverted microscope.
Data analysis
Statistical significance was assessed by ANOVA. Differences
identified by ANOVA were pinpointed by the Tukey-Kramer
test.
RESULTS
RV39 infection stimulates C-X-C chemokine
production from human airway epithelial cells
Well-differentiated human primary airway epithelial
cells were infected apically with RV39 (MOI of 1) and
incubated for 24 h. Washings of apical surface and
medium from the basolateral chamber were collected
for quantification of IL-8, ENA-78, and GRO- proteins
by ELISA. Cell cultures infected with equal volumes of
HeLa cell extract (sham) served as controls. Under
these conditions, RV39 significantly increased the ba-
solateral secretion of all three chemokines compared
with sham-treated controls (Fig. 1). There were no
changes in the concentration of chemokines in the
apical secretions (data not shown).
H. influenzae increases RV39-stimulated C-X-C
chemokine production from airway epithelial cells
To examine the effect of bacterial infection on RV39
stimulated C-X-C chemokines, we initially determined
the optimal dose of bacteria and incubation time.
Well-differentiated airway epithelial cell cultures were
infected with H. influenzae at MOI of 0.1 or 1 and 10
and incubated for 4, 8, or 24 h. This was followed by
RV39 infection for 24 h. We then measured the release
of IL-8 as well as lactose dehydrogenase (LDH), a
marker of cell death, in the basolateral chamber. We
also examined cultures for phenotypic evidence of cell
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damage. IL-8 release in the basolateral chamber was
found to be maximum when cultures were incubated
with H. influenzae at MOI of 1 for 8 h followed by RV39
for 24 h (data not shown). Based on the results of these
initial studies, we used H. influezae at MOI of 1 and
incubation time of 8 h for further studies. Increasing
the incubation time of cultures with bacteria to 12 h
before RV39 infection did not significantly increase
IL-8 release. However, a further increase in incubation
time to 24 h caused cytotoxic effects.
Cultures were infected apically with bacteria and
incubated for 8 h. Unbound bacteria were removed by
washing the apical surface, and cells were then incu-
bated with RV39 as before. Secreted IL-8, ENA-78, and
GRO- in the basolateral media were measured by
ELISA. Cell cultures infected with both bacteria and
RV39 secreted significantly more IL-8, ENA-78, and
GRO- than cells infected with RV39 or H. influenzae
alone (Fig. 1). The observed stimulatory effect was
additive.
Previously, we have shown that RV39 infection stim-
ulates increased IL-8 expression in 16HBE14o- cells and
that this expression of IL-8 is transcriptionally regulated
(31). To examine whether H. influenzae potentiated
RV39-induced IL-8 in 16HBE14o- cells, we infected
these cells with bacteria for 8 h followed by RV39 for
24 h and measured IL-8 secretion in the supernatants.
On average, RV39 alone stimulated a threefold increase
of IL-8 compared with sham controls, whereas H.
influenzae alone stimulated IL-8 twofold over mock-
infected controls. However, bacteria and virus together
increased IL-8 production from the 16HBE14o- cells in
a synergistic (greater than additive) manner (8-fold
over control, Fig. 2A). The observed effect was not
unique to H. influenzae strain 12, as we observed similar
synergistic effects with three other nontypeable strains
isolated from COPD patients (data not shown). How-
ever, heat-killed H. influenzae did not potentiate RV-
induced IL-8 from airway epithelial cells, indicating
that metabolically active bacteria are required. To
examine if the IL-8 production is transcriptionally
regulated, 16HBE14o- cells were transfected with hIL-
8/Luc and Renilla luciferase and infected with bacteria
or/and virus as above. Luciferase activity was measured
24 h postinfection. RV39 and H. influenzae increased
mean IL-8 promoter activity by three and fourfold,
respectively, whereas bacteria and virus together in-
creased promoter activity by eightfold (Fig. 2B). These
results suggested that IL-8 expression in response to
virus and bacteria is regulated at transcriptional level.
H. influenzae increases RV39 binding to airway
epithelial cells
We hypothesized that the observed increase in RV39-
induced IL-8 expression in H. influenzae-infected cells is
due to increased binding of RV39. To test this hypoth-
esis, 35S-labeled RV39 or similarly prepared sham con-
trol was incubated at 4°C for 1 h with uninfected
16HBE14o- epithelial cells or cells infected with H.
influenzae at MOI of 1 for 8 h, and cell-associated
radioactivity was determined. Pilot studies showed that
binding of virus to airway epithelial cells was optimal at
1 h and that this did not change with H. influenzae
infection. Specific binding was determined by subtract-
ing nonspecific CPM recovered from cells treated with
sham control, as well as the background CPM recov-
ered from RV-infected cells after EDTA treatment.
Binding of RV39 to both infected and uninfected cells
increased with greater concentrations of added virus
and reached saturation (Fig. 3A). Binding of RV was
Figure 1. H. influenzae potentiates RV-39 induced IL-8 (A),
ENA-78 (B), and GRO- (C) expression in primary mucocili-
ary-differentiated human tracheal epithelial cells. Primary
human airway epithelial cells differentiated into mucociliary
phenotype were infected with H. influenzae at MOI of 1 and
incubated for 8 h. Unbound bacteria were removed, and cells
were infected with RV39 (MOI of 1 for 1 h) apically. Cultures
incubated with equal volumes of sham-infected HeLa cell
extracts served as controls. Chemokine release in basolateral
chamber was measured 24 h later by ELISA. Bars are mean 
se of 3 experiments; *different from sham infected, P  0.05,
ANOVA.
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substantially inhibited by neutralizing Ab to ICAM1
(Fig. 3B), indicating specific binding. Maximum RV39
binding was increased in cells infected with H. influen-
zae compared with uninfected cells, consistent with the
notion that infection with H. influenzae increases RV39-
induced IL-8 expression by augmenting binding of RV
to its epithelial cell receptor.
H. influenzae increases expression of ICAM-1 and
TLR3
Next, we examined whether the increased binding of
RV39 to H. influenzae-infected cells and the resultant
increased production of C-X-C chemokines are associ-
ated with altered expression of ICAM-1 and TLR3.
Binding of major subgroup RV to ICAM-1 is a prereq-
uisite for airway epithelial cell IL-8 expression (31, 32).
Although RV is a single-stranded RNA virus, during
replication it makes double-stranded (ds)-RNA inter-
mediates. TLR3, a type I transmembrane protein, me-
diates immune responses to dsRNA (33). TLR3 is
expressed in airway epithelial cells (34, 35), although
the subcellular localization in differentiated polarized
cells has not been resolved. Airway epithelial cells are
activated by dsRNA (35–38), suggesting that TLR3
mediates RV-induced responses. However, the require-
ment of TLR3 for RV-induced responses has not been
assessed.
16HBE14o- cells were infected with H. influenzae as
described above, and the total and cell surface expres-
sion of ICAM-1 and TLR3 was determined by flow
Figure 3. Binding of RV39 to 16HBE14o- cells is increased in
cells infected with H. influenzae. 16HBE14o- cells grown to
80% confluence, serum-starved overnight and infected with
H. influenzae as described in Fig. 2. A) Cells were then
incubated with 35S-labeled RV39 or same volume 35S- labeled
sham in the presence or absence of 10 mM EDTA for 1 h at
4°C. Unbound radiolabeled bacteria were removed, cells were
lysed, and radioactivity was determined. Specific binding was
calculated by subtracting radioactivity recovered from cells
incubated with sham, as well as counts recovered in the
presence of EDTA, from radioactivity obtained in the absence
of EDTA. Three independent experiments were carried out
in triplicate; results from a representative experiment are
shown. B) Specificity of RV39 binding to 16HBE14o- cells
infected with H. influenzae was determined by preincubating
cells with normal IgG or mAb to ICAM-1 for 1 h. 35S-labeled
virus was added and binding determined. Bars are mean  se
of 3 experiments; *different from cultures uninfected with H.
influenzae, P  0.05, ANOVA.
Figure 2. H. influenzae synergistically increases RV-39 stimu-
lated IL-8 protein and IL-8 promoter activity in 16HBE14o-
cells. A) Epithelial cells grown to 80% confluence were serum
starved overnight, infected with H. influenzae at MOI of 1, and
incubated for 8 h. Unbound bacteria were removed, and cells
were infected with RV39 at MOI of 1 for 1h. Medium was then
replaced and cells further incubated for another 24 h. IL-8
release in medium was determined by ELISA. Bars are
mean  se of 3 experiments; *different from uninfected, P 
0.05, ANOVA. B) For promoter assays, cells were transfected
with hIL-8/Luc and Renilla 24 h before infection and lucif-
erase activity determined by luminometer. Data were cor-
rected for transfection efficiency and expressed as fold in-
crease over uninfected control cells. Bars are mean  se of 3
experiments; *different from infection with RV or H. influen-
zae alone, P  0.05, ANOVA.
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cytometry. Cells infected with H. influenzae showed in-
creased expression of both ICAM-1 and TLR3 (Fig. 4A
and B). Whereas expression of ICAM-1 increased mainly
on the cell surface, TLR3 expression increased mainly in
the intracellular compartment (Fig. 4C and D). Increased
expression of ICAM-1 and TLR3 in well-differentiated
human primary airway epithelial cell cultures on H.
influenzae was confirmed by immunofluorescence. Similar
to 16HBE14o- cells, H. influenzae infection increased
expression of both ICAM-1 and TLR3 in these cultures
(Fig. 4E and F). Confocal micrographs and Z-sections
demonstrate that ICAM-1 expression is primarily con-
fined to the apical surface, whereas TLR3 is localized
primarily to the cell cytoplasm (Figs. 4E–H). These results
suggest that H. influenzae increases RV39 binding to
epithelial cells and potentiates RV39-stimulated chemo-
kine expression by increasing the expression of the viral
receptors ICAM-1 and TLR3.
RV39-stimulated IL-8 expression is partially
dependent on TLR3
Next, we examined to what extent TLR3 contributes to
RV39-stimulated IL-8 expression in airway epithelial cells
taking two approaches. In the first approach, TLR3 ex-
pression in 16HBE14o- cells was partially blocked using
specific siRNA, and the effects on H. influenzae- and
RV39-induced IL-8 promoter activity were determined.
Cells transfected with nontargeting siRNA served as con-
trols in this set of experiments. TLR3 expression was
assessed by immunoblotting. As observed earlier, infec-
tion of epithelial cells with H. influenzae increased TLR3
expression (Fig. 5A). Transfection of specific siRNA de-
creased the TLR3 expression in both uninfected and H.
influenzae-infected cells. We then examined the effect of
siRNA on transcription from the IL-8 promoter. Cells
transfected with TLR3 siRNA (10 pmol) showed signifi-
cantly decreased IL-8 promoter activity when stimulated
by either RV39 alone or H. influenzae and RV39 (Fig. 5B).
As would be expected, siRNA against TLR3 had no effect
on H. influenzae-induced IL-8 expression. A second TLR3
siRNA showed similar effects (Fig. 5B). These results
indicate that, in addition to ICAM-1, TLR3 is required for
maximal RV39-induced IL-8 production.
In a second approach, HEK293 cells stably trans-
fected with TLR3 or empty vector were infected with
RV39. These cells express ICAM-1 constitutively but do
not express TLR3. HEK293 cells transfected with TLR3
expressed large amounts of TLR3 with no change in
expression of ICAM-1 (Fig. 6A and B). On average, cells
expressing TLR3 produced 13-fold higher IL-8 levels
on RV infection than untransfected HEK293 cells (Fig.
Figure 4. Increased expression ICAM-1 and
TLR3 in H. influenzae-infected cells. 16HBE14o-
cells were infected with H. influenzae as de-
scribed, immunostained with antibodies to
ICAM-1 or TLR3, and analyzed by flow cytometry.
A and B) Representative histograms of fluores-
cence intensity of permeabilized 16HBE14o- cells
immunostained with ICAM-1 and TLR3 Ab, re-
spectively. Similar results were obtained in 2
additional experiments. Intracellular expres-
sion of ICAM-1 (C) and TLR3 (D) was calculated
by subtracting the mean fluorescence intensity
of nonpermeabilized cells from permeabilized
cells. Expression of both ICAM-1 (E) and TLR3
(F) is increased in well-differentiated primary
airway epithelial cells infected with H. influenzae
compared with uninfected controls, as deter-
mined by immunofluorescent confocal micros-
copy. Z sections show cellular localization of
ICAM-1 (G) and TLR3 (H). ICAM-1 is localized
primarily to the cell surface, whereas TLR3 is
primarily found in the cell cytoplasm.
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6C). RV39 RNA was detected by RT-PCR in both cell
types 24 h postinfection (Fig. 6D), indicating that TLR3
is not required for RV infection but may be required for
amplification of chemokine response. Taken together
with the previous data, these data suggest that prior
infection with H. influenzae increases RV39-induced
IL-8 expression in part by increasing expression of
TLR3.
H. influenzae-induced TLR3 expression is mediated
by TNF-
Next, we wished to determine the mechanism by which
H. influenzae induces TLR3 expression in airway epithe-
lial cells. Instillation of bacterial lipopolysaccharides
into rat lungs induces bronchial epithelial cell ICAM-1
expression in a TNF--dependent manner (39). TNF-
increases airway epithelial cell ICAM-1 expression (40).
We therefore hypothesized that TNF-, produced by
epithelial cells in response to H. influenzae infection, is
at least partially responsible for the observed increases
in TLR3 expression and RV-induced IL-8 production in
H. influenzae-infected cells. Initially, we established that
16HBE14o- cells secrete TNF- within 5–15 min of
infection with H. influenzae (Fig. 7A). To detect TNF-
in the cell culture supernatant, prior blocking of
TNFR1 with neutralizing Ab was needed, apparently
because TNF- is rapidly bound to its receptor, which is
highly abundant in 16HBE14o- cells. Next, we exam-
ined the effect of exogenous TNF- on TLR3 expres-
sion. 16HBE14o cells were incubated with 1 ng/ml of
TNF- for 24 h, and total TLR3 expression was mea-
sured by flow cytometry. TNF- increased the expres-
sion of TLR3, as assessed by mean fluorescence inten-
sity, approximately twofold (Fig. 7B and C). After
establishing that TNF- can in fact increase TLR3
expression, we examined whether neutralizing Ab can
inhibit the augmented IL-8 production induced by
RV39 in H. influenzae-infected cells. Cells were incu-
bated with H. influenzae or TNF- (1 ng/ml) in the
presence of 1 ng/ml TNF- neutralizing Ab or normal
IgG for 8 h, and unbound bacteria were removed. Cells
were then incubated with RV39 in presence of TNF-
neutralizing Ab for another 12 h, and IL-8 released was
quantified by ELISA (Fig. 7D). Previous work from our
laboratory has shown that RV39-induced IL-8 responses
do not require airway epithelial cell TNF- production
(31). In contrast, TNF- neutralizing Ab partially inhib-
ited IL-8 expression induced by the combination of H.
influenzae and RV. Incubation with normal IgG had no
effect. Together, these data suggest that H. influenzae
increases expression of the TLR3 viral receptor via
TNF-.
DISCUSSION
Nontypeable H. influenzae has been isolated from the
airways of clinically stable COPD patients (1–3) and has
also been associated with COPD exacerbations (4).
Between 27 to 56% of COPD exacerbations are associ-
ated with respiratory viral infections, and RV is the most
common virus isolated (8–10). Respiratory viruses are
more likely to be isolated in patients with a history of
frequent COPD exacerbations (9), suggesting that pa-
tients with frequent exacerbations are more susceptible
to viral infection (15). Nevertheless, little information
exists regarding potential interactions between viruses
and bacteria in the pathogenesis of COPD exacerba-
tions. We hypothesized that H. influenzae infection
increases expression of airway epithelial cell ICAM-1
and TLR3, leading to increased RV binding and exag-
gerated RV-induced chemokine responses. We found
that infection with nontypeable H. influenzae increases
Figure 5. TLR3 is required for RV39-induced IL-8 expression.
A) Infection with H. influenzae increased expression of TLR3
compared with uninfected controls. In contrast to nontarget-
ing (NT) siRNA, TLR3 siRNA specifically decreased expres-
sion of TLR3 in uninfected and H. influenzae-infected cells. A
representative immunoblot is shown. B) TLR3 siRNA de-
creased the RV39-stimulated IL-8 promoter activity. Upper
panel) TLR3 siRNA1 (from Santa Cruz Biotechnology). Lower
panel) TLR3 siRNA2 (from Dharmacon). Bars are mean  se
of 3 experiments; *different from nontargeting siRNA, P 
0.05, ANOVA. Cells transfected with nontarget RNA had no
effect.
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the expression of ICAM-1 and TLR3 in human airway
epithelial cells differentiated into mucociliary pheno-
type, as well as 16HBE14o- cells growing as monolayers.
We further showed that H. influenzae increases binding
of RV39 to airway epithelial cells, leading to additive or
synergistic increases the RV39-stimulated C-X-C chemo-
kine expression. TNF- was required for this response.
Finally, we found that, in airway epithelial cells, TLR3 is
required for maximal RV39-induced IL-8 expression.
Recently, we showed that RV39 infection of human
airway epithelial cells is sufficient to activate phosphoti-
dylinositol-3 kinase within minutes of infection, sug-
gesting that ICAM-1 engagement is sufficient to activate
signaling pathways leading to IL-8 expression (31).
ICAM-1 is required for major subgroup RV-induced
responses (31, 32). Cells differentiated into a psue-
dostratified mucociliary phenotype are harder to infect
with major subgroup RV than cells differentiated into a
squamous phenotype, which express higher levels of
ICAM-1 (41). Conversely, erythromycin, which reduces
expression of ICAM-1, inhibits RV binding to cells (42).
Thus, alterations in receptor expression may modulate
Figure 6. HEK293 cells stably expressing TLR3
produce more IL-8 in response to RV39 infec-
tion. A) HEK293 cells stably transfected with
TLR3 or empty vector express comparable
amounts of ICAM-1. B) TLR3 expression is
observed only in cells transfected with TLR3. C)
HEK293 cells stably expressing TLR3 produced
increased IL-8 in response to RV39 infection
compared with HEK293 cells expressing empty
vector. D) Cell lines demonstrated similar levels
of RV39 RNA, as determined by RT-PCR. Bars
are mean  se of 3 experiments; *different
from empty vector, P  0.05, ANOVA
Figure 7. TNF- is sufficient to increase airway
epithelial cell TLR3 expression, and is required
for maximal RV39-induced IL-8 expression in
H. influenzae preinfected cells. A) H. influenzae
stimulates release of TNF- from 16HBE14o-
cells. B) Effect of exogenous TNF- (1 ng/ml
for 24 h) on TLR3 expression, as measured by
flow cytometry, a representative histogram. C)
TNF- increased expression of TLR3 by 2-fold,
and TLR-3 was localized primarily to the intra-
cellular compartment. Data shown are from a
representative experiment of 3 independent
experiments. D) Effect of neutralizing Ab
against TNF- on RV39-induced IL-8 expres-
sion in H. influenzae infected or TNF--treated
cells. Previous work from our laboratory has
shown that RV39-induced IL-8 responses do not
require airway epithelial cell TNF- production
(31). In contrast, in cells preinfected with H.
influenzae, treatment with TNF- neutralizing
Ab, but not normal IgG, significantly decreased
IL-8 expression. Bars are mean  se of 3
experiments; *different from control IgG, P 
0.05, ANOVA.
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RV infectivity and responsiveness. In the present study,
H. influenzae infection induced alterations of airway
epithelial cell ICAM-1, which were associated with
increases in RV binding and subsequent chemokine
expression. Live but not heat-killed bacteria potenti-
ated the RV-induced chemokine expression, indicating
the requirement of metabolically active bacteria for the
above processes. Together, these data provide a mech-
anism by which patients with frequent COPD may
become more susceptible to viral infection (15). Fur-
thermore, increased expression of ELR() C-X-C chemo-
kines may stimulate COPD exacerbations by inducing an
exaggerated neutrophilic inflammatory response.
In addition to ICAM-1 expression, infection of both
primary and 16HBE14o- airway epithelial cells with H.
influenzae increased expression of TLR3. H. influenzae-
stimulated TLR3 expression was mainly intracellular in
location. TLR3 is an evolutionarily conserved pathogen
recognition receptor that recognizes and binds dsRNA
and activates transcription factors with a central role in
innate immunity, NF-	B and IFN-regulatory factor 3
(43). It has recently been shown in BEAS-2B human
bronchial epithelial cells that RV infection increases
surface TLR3 expression (38). Although we did not
systematically examine the effect of RV on TLR3 ex-
pression, RV appeared to increase the expression of
this viral receptor, but perhaps not to the same degree
as it does ICAM-1 (data not shown). Infection with
other single-stranded RNA viruses, respiratory syncytial
virus (RSV), and influenza A, increases TLR3 expres-
sion in A549 respiratory epithelial cells and BEAS-2B
cells, respectively (30, 44). Poly (I:C), a synthetic analog
of viral dsRNA, has recently been shown to increase
TLR3 expression in primary human small airway epi-
thelial cells (45).
Although the induction of TLR3 expression by RNA
viruses or dsRNA may not be surprising, positive regu-
lation of TLR3 due to bacterial infection of the respi-
ratory epithelium has not been demonstrated previ-
ously. In BEAS-2B cells, expression of TLR3 was
positively regulated by influenza A as well as dsRNA but
not by other inflammatory mediators including bacte-
rial LPS. Coculture of HT29 human colon adenocarci-
noma cells with bacterial isolates from the rectal mu-
cosa has recently been shown to increase TLR3
expression (46).
H. influenzae has previously been shown to stimulate
respiratory epithelial cell ICAM-1 expression (17). This
effect was not dependent on synthesis of lipooligosac-
charide or on selected H. influenzae adhesins that
promote high-affinity bacterial adherence. TNF- in-
creases airway epithelial cell ICAM-1 expression (40),
and instillation of bacterial lipopolysaccharides into rat
lungs induces bronchial epithelial cell ICAM-1 expres-
sion in a TNF--dependent manner (39). In the present
study, live H. influenzae stimulated secretion of TNF-
within the first 5–15 min of infection. We therefore
hypothesized that H. influenzae-induced changes in RV
receptor expression were mediated, at least in part, by
TNF-. TNF- increased the expression of TLR3 in
airway epithelial cells approximately twofold. Further-
more, neutralizing Ab against TNF- inhibited RV39-
stimulated IL-8 production in H. influenzae-infected
cells. These data are consistent with the notion that
airway epithelial production of TNF- is required for H.
influenzae-induced changes in RV receptor expression.
RV39-induced IL-8 production in H. influenzae-prein-
fected cells is unlikely to be due to the direct effects of
TNF- on IL-8 transcription, since the effect of RV39
alone on IL-8 expression does not require TNF- (31).
We found that TLR3-specific siRNA, which blocked
both constitutive and H. influenzae-stimulated TLR3
expression in airway epithelial cells, also inhibited the
RV-stimulated IL-8 production. Decreases in TLR3 ex-
pression and RV-stimulated IL-8 production were not
observed when cells were transfected with nontargeting
siRNA. Furthermore, HEK293 cells stably transfected
with TLR3 produced high amounts of IL-8 in response
to RV infection. Together, these findings suggest that
TLR3 (specifically intracellular TLR3) is required for
maximal IL-8 expression and sufficient, at least to some
degree, for IL-8 expression in response to RV infection.
Since RV dsRNA does not exist extracellularly, H.
influenzae-induced up-regulation of intracellular TLR3
expression was likely responsible for the observed in-
crease in chemokine expression. Intracellular TLR3
has previously been reported to be required for maxi-
mal IL-8 expression and NF-	B transactivation to RSV
and influenza A, respectively (30, 44). In contrast, it has
recently been shown that neutralizing Ab to TLR3
increases chemokine expression stimulated by RV in
BEAS-2B human bronchial epithelial cells (38). The
discrepancy between this result and our own may be
due to different method of blocking TLR3. Although
neutralizing Ab can block surface-expressed TLR3,
siRNA blocked global expression of TLR3 and hence
may be more effective in inhibiting responses to dsRNA
intermediates generated during the RV replication
phase. The signaling pathway by which TLR3 engage-
ment activates C-X-C chemokine production remains
unclear.
In the aforementioned study, neutralizing Ab to
TLR3 also increased RV replication (38). Similarly,
TLR3-specific ligand inhibits hepatitis B virus replica-
tion (47), consistent with the notion that TLR3 medi-
ates antiviral activity. TLR3-specific siRNA had no effect
on RSV replication (44). Similarly, in the present study,
HEK293 cells, which express ICAM-1 but not TLR3,
showed similar levels of RV39 RNA by RT-PCR com-
pared with cells overexpressing TLR3 suggesting TLR3
may not affect RV replication.
Finally, our observations of increased chemokine
production in response to RV infection lie in contrast
to data from Lopez-Souza et al. (41), who observed no
significant increase in IL-8. The precise explanation for
this discrepancy is unclear. We used a pure culture of
passage 1 epithelial cells and did not deprive the cells of
growth factors and hormones prior to RV infection.
Our preliminary results suggest that such deprivation
attenuates the IL-8 response to RV39 (U. Sajjan and M.
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Hershenson, unpublished data). We also used a differ-
ent serotype of RV.
In summary, we have shown that infection of airway
epithelial cells with H. influenzae increases expression of
the RV receptors ICAM-1 and TLR3. In addition, we
found that, like ICAM-1, TLR3 regulates IL-8 expres-
sion stimulated by major subgroup RV. Together, these
data provide a mechanism for increased susceptibility
to RV infection in COPD patients who are also infected
with nontypeable H. influenzae. Indeed, studies in our
laboratory indicate that TLR3 expression is increased
in the small airways of at least some COPD patients (U.
Sajjan, D. Arenberg, and M. Hershenson, unpublished
data). Further investigation addressing potential inter-
actions between viruses and bacteria in the pathogen-
esis of COPD exacerbations is therefore warranted.
This work was supported by National Institutes of Health
grants HL56399, HL81420, and HL82550 and the Cystic
Fibrosis Foundation.
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SPECIFIC AIM
Chronic obstructive pulmonary disease (COPD) is a
chronic, progressive disease with intermittent acute
exacerbations associated with viral and/or bacterial
infections. Nontypeable H. influenzae has been isolated
from airways of clinically stable COPD patients, suggest-
ing that it can cause chronic infection. Rhinovirus
(RV), a single-stranded RNA virus that is responsible
for most of the common colds, is an important trigger
of acute exacerbations in COPD patients. Respiratory
viruses are more likely to be isolated in patients with a
history of frequent COPD exacerbations, suggesting
that patients with frequent exacerbations are more
susceptible to viral infection. Nevertheless, little infor-
mation exists regarding potential interactions between
viruses and bacteria in the pathogenesis of COPD
exacerbations. In the present study, we investigated the
cooperative effects of H. influenzae and RV on ELR()
C-X-C chemokine production from airway epithelial
cells. We hypothesized that H. influenzae infection in-
creases expression of airway epithelial cell intercellular
adhesion molecule (ICAM)-1 and Toll-like receptor
(TLR)-3, leading to increased RV binding and exagger-
ated RV-induced chemokine responses.
PRINCIPAL FINDINGS
1. H. influenzae increases RV39-stimulated C-X-C
chemokine production from airway epithelial cells
Well-differentiated human primary airway epithelial
cells grown at air-liquid interface were infected apically with
RV39 at an multiplicity of infection (MOI) of 1 and incu-
bated for 24 h. Medium from the basolateral chamber was
collected for quantification of interleukin (IL)-8, epithelial-
derived neutrophil attractant (ENA)-78, and growth-related
oncogene (GRO)- proteins by ELISA. Cultures infected
with HeLa cell extract (sham) served as control. RV39
significantly increased the basolateral secretion of all three
chemokines compared with controls (Fig. 1).
To examine the effect of bacterial infection on
RV39-stimulated chemokines, well-differentiated airway
epithelial cell cultures were infected with H. influenzae
at MOI of 1 and incubated for 8 h. Unbound bacteria
were removed by washing of the apical surface, and
cells were incubated with RV39 as before. Cell cultures
infected with both bacteria and RV39 secreted signifi-
cantly more IL-8, ENA-78, and GRO- than cells in-
fected with RV39 or H. influenzae alone (Fig. 1).
We found similar cooperative effects of H. influenzae
and RV on transcription from the IL-8 promoter in
16HBE14o- human bronchial epithelial cells, suggest-
ing that IL-8 expression in response to virus and
bacteria is regulated at the transcriptional level.
2. H. influenzae increases RV39 binding to airway
epithelial cells and expression of viral receptors
ICAM-1 and TLR3
We hypothesized that the observed increase in RV39-
induced IL-8 expression in H. influenzae-infected cells is
due to increased binding of RV39. To test this, 35S-
labeled RV39 was incubated at 4°C for 1 h with unin-
fected 16HBE14o- cells or cells infected with H. influ-
enzae at MOI of 1 for 8 h, and cell-associated
radioactivity was determined. Maximal RV39 binding
was increased in cells infected with H. influenzae com-
pared with uninfected cells. These data are consistent
with the notion that infection with H. influenzae in-
creases RV39-induced IL-8 expression by augmenting
binding of RV to its epithelial cell receptor.
Next, we examined whether the increased binding of
RV39 to H. influenzae-infected cells and the resultant
increased production of C-X-C chemokines are associ-
ated with altered expression of ICAM-1 and TLR3.
Binding of major subgroup RV to ICAM-1 is a prereq-
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uisite for airway epithelial cell IL-8 expression. TLR3
mediates immune responses to double-stranded (ds)-
RNA. Although RV is a single-stranded RNA virus,
during replication it makes dsRNA intermediates. 16
HBE14o- cells were infected with H. influenzae as de-
scribed above, and the total and cell surface expression of
ICAM-1 and TLR3 was determined by flow cytometry.
Cells infected with H. influenzae showed increased expres-
sion of both ICAM-1 and TLR3 (Fig. 2A and B). Whereas
expression of ICAM-1 increased mainly on the cell sur-
face, TLR3 expression increased mainly in the intracellu-
lar compartment (Figs. 2C and D). Similar to 16HBE14o-
cells, H. influenzae infection increased expression of both
ICAM-1 and TLR3 in differentiated human primary air-
way epithelial cell cultures. Confocal micrographs and
Z-sections demonstrate that ICAM-1 expression is primar-
ily confined to the apical surface, whereas TLR3 is local-
ized primarily to the cell cytoplasm (Figs. 2E–H). These
results suggest that H. influenzae increases RV39 binding
to epithelial cells and potentiates RV39-stimulated chemo-
kine expression by increasing expression of the viral
receptors ICAM-1 and TLR3.
3. RV39-stimulated IL-8 expression is partially
dependent on TLR3; H. influenzae-induced TLR3
expression is mediated by TNF-
Next, we examined to what extent TLR3 contributes to
RV39-stimulated IL-8 expression in airway epithelial
cells. In the first approach, TLR3 expression in
16HBE14o- cells was partially blocked using specific
siRNA, and the effects on H. influenzae- and RV39-
induced IL-8 promoter activity were determined. Cells
transfected with two different preparations of TLR3
siRNA, but not nontargeting siRNA, showed signifi-
cantly decreased IL-8 promoter activity when stimu-
lated by either RV39 alone or H. influenzae and RV39.
siRNA against TLR3 had no effect on H. influenzae-
induced IL-8 expression. These results indicate that
TLR3 is required for maximal RV39-induced IL-8 pro-
duction. In a second approach, human embryonic
kidney (HEK)-293 cells stably transfected with TLR3 or
empty vector were infected with RV39. These cells do
not express TLR3 constitutively. On average, cells ex-
pressing TLR3 produced 13-fold higher IL-8 levels on
RV infection than untransfected HEK293 cells. To-
gether with the previous data, these data suggest that
prior infection with H. influenzae increase RV39-induced
IL-8 expression in part by increasing expression of TLR3.
We hypothesized that TNF-, produced by epithelial
cells in response to H. influenzae infection, is at least
partially responsible for the observed increases in TLR3
expression. 16HBE14o- cells secrete TNF- within 5–15
min of infection with H. influenzae. TNF- also in-
creased the expression of TLR3 approximately fivefold.
Incubation with TNF- neutralizing antibody, but not
normal IgG, caused dose-dependent inhibition of IL-8
expression induced by the combination of H. influenzae
and RV. In contrast, previous work from our laboratory
has shown that RV39-induced IL-8 responses do not
require airway epithelial cell TNF- production. To-
gether, these data suggest that H. influenzae increases
expression of the TLR3 viral receptor via TNF-.
CONCLUSIONS AND SIGNIFICANCE
Little information exists regarding potential interactions
between viruses and bacteria in the pathogenesis of
COPD exacerbations. We hypothesized that H. influenzae
infection increases expression of airway epithelial cell
ICAM-1 and TLR3, leading to increased RV binding and
exaggerated RV-induced chemokine responses. The re-
quirement of TLR3, an evolutionarily conserved pathogen
Figure 1. H. influenzae potentiates RV-39 induced IL-8 (A),
ENA-78 (B), and GRO- (C) expression in primary mucocili-
ary-differentiated human tracheal epithelial cells. Primary
human airway epithelial cells differentiated into mucociliary
phenotype were infected with H. influenzae at MOI of 1 and
incubated for 8 h. Unbound bacteria were removed, and cells
were infected with RV39 (MOI of 1 for 1 h) apically. Cultures
incubated with equal volumes of sham-infected HeLa cell extracts
served as controls. Chemokine release in basolateral chamber was
measured 24 h later by ELISA. Bars are mean  se of 3 experi-
ments; *different from sham infected, P  0.05, ANOVA.
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recognition receptor that recognizes and binds dsRNA, for
RV-induced chemokine expression has not yet been tested.
We found that infection with nontypeable H. influen-
zae increases the expression of ICAM-1 and TLR3 in
human airway epithelial cells differentiated into muco-
ciliary phenotype, as well as 16HBE14o- cells growing as
monolayers. We further showed that H. influenzae in-
creases binding of RV39 to airway epithelial cells,
leading to cooperative increases the RV39-stimulated
C-X-C chemokine expression. Together, these data
provide a mechanism by which prior infection with
nontypeable H. influenzae, as occurs in patients with
COPD, may increase susceptibility to RV infection (Fig.
3). Although the induction of TLR3 expression by RNA
viruses or dsRNA may not be surprising, positive regu-
lation of TLR3 due to bacterial infection of the respira-
tory epithelium has not been demonstrated previously.
In addition, we found that TLR3-specific siRNA,
which blocked both constitutive and H. influenzae-
stimulated TLR3 expression in airway epithelial cells,
also inhibited the RV-stimulated IL-8 production. Fur-
thermore, HEK293 cells stably transfected with TLR3
produced high amounts of IL-8 in response to RV
infection. Together, these findings show for the first
time that TLR3 is required for maximal IL-8 expression
and sufficient, at least to some degree, for IL-8 expres-
sion in response to RV infection.
Preliminary studies in our laboratory indicate that
TLR3 expression is increased in the small airways of
COPD patients (U. Sajjan, D. Arenberg, and M. Hersh-
enson, unpublished data). Further investigation ad-
dressing potential interactions between viruses and
bacteria in the pathogenesis of COPD exacerbations is
therefore warranted.
Figure 3. Summary schematic depicting a cellular mechanism
by which prior infection with H. influenzae increases suscep-
tibility of airway epithelial cells to RV infection, leading to
increased chemokine expression and COPD exacerbation.
Figure 2. Increased expression ICAM-1 and
TLR3 in H. influenzae-infected cells. 16HBE14o-
cells were infected with H. influenzae as de-
scribed, immunostained with antibodies to
ICAM-1 or TLR3, and analyzed by flow cytom-
etry. A and B) Representative histograms of
fluorescence intensity of permeabilized
16HBE14o- cells immunostained with ICAM-1
and TLR3 Ab, respectively. Similar results were
obtained in 2 additional experiments. Intracel-
lular expression of ICAM-1 (C) and TLR3 (D)
was calculated by subtracting the mean fluores-
cence intensity of nonpermeabilized cells from
permeabilized cells. Expression of both ICAM-1
(E) and TLR3 (F) is increased in well-differenti-
ated primary airway epithelial cells infected
with H. influenzae compared with uninfected
controls, as determined by immunofluorescent
confocal microscopy. Z sections show cellular
localization of ICAM-1 (G) and TLR3 (H).
ICAM-1 is localized primarily to the cell surface,
whereas TLR3 is primarily found in the cell
cytoplasm.
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